Interaksi Paroksetin dan Tranilsipromin

Paroksetin dan Tranilsipromin: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Paroksetin (PAROXETINE HYDROCHLORIDE) · berlaku sejak 2026-09-16

Mayor

Examples selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Pimozide and Thioridazine Clinical Impact Paroxetine HCL CR should not be used in patients receiving medications that can prolong QT interval and are metabolized by CYP450 2D6 such as thioridazine or pimozide (see Contraindications and Warnings and Precautions ) Intervention…

Interaksi obatmenyebut TranilsiprominLihat label di DailyMed
Mayor

Paroxetine HCL CR is contraindicated in patients: Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [See Warnings and Precautions ( 5.2 ), Drug Interactions (7)].

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

Concomitant use of monoamine oxidase inhibitors (MAOIs) or use within 14 days of discontinuing a MAOIs.

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

The concomitant use of Paroxetine HCL CR with MAOIs is contraindicated.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Tranilsipromin (Tranylcypromine Sulfate) · berlaku sejak 2025-07-25

Mayor

Do not take tranylcypromine sulfate tablets if you: take certain medicines, including: antidepressants, such as: other monoamine oxidase inhibitors (MAOIs) selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) tricyclic antidepressants other antidepressants, such as amoxapine, bupropion, maprotiline, nefazodone,…

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Concomitant use or use in rapid succession with other MAOIs; selective serotonin reuptake inhibitors; serotonin and norepinephrine reuptake inhibitors; tricyclic antidepressants; sympathomimetic drugs; and numerous other drugs.

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

…Use of Tranylcypromine Sulfate Tablets Drug Classes Non-selective H1 receptor antagonists Antidepressants including but not limited to: Other monoamine oxidase inhibitors (MAOIs) Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) Tricyclic antidepressants Other antidepressants (e.g., amoxapine, bupropion,…

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

Serotonin Syndrome The development of a potentially life-threatening serotonin syndrome has been reported with MAOIs when used concomitantly with other serotonergic drugs.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

The concomitant use, or use in rapid succession, of tranylcypromine sulfate tablets with other serotonergic drugs is contraindicated.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.